Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,786,687 papers from all fields of science
Search
Sign In
Create Free Account
Wells syndrome
Known as:
well's syndrome
, syndrome wells
, Eosinophilic cellulitis
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Cellulitis
Eosinophilia
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Eosinophilic Cellulitis Successfully Treated with Colchicine
M. Ozturk
,
E. Uçan
,
I. Ibiloğlu
Indian Dermatology Online Journal
2019
Corpus ID: 195785737
Review
2018
Review
2018
Wells syndrome secondary to influenza vaccination: A case report and review of the literature
Tyler Safran
,
M. Masckauchan
,
J. Maj
,
Lawrence Green
Human Vaccines & Immunotherapeutics
2018
Corpus ID: 4729499
ABSTRACT Vaccinations have been shown repeatedly to be extremely safe with low incidence of complications. Given the rarity…
Expand
Review
2017
Review
2017
Dapsone treatment for eosinophilic anular erythema
R. Alharbi
,
R. Alharbi
,
J. Perić
,
Hans Wolff
,
A. Wollenberg
Journal of the European Academy of Dermatology…
2017
Corpus ID: 206043577
outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progressi on…
Expand
2014
2014
A possible mechanism in the recruitment of eosinophils and Th2 cells through CD163+ M2 macrophages in the lesional skin of eosinophilic cellulitis
T. Fujimura
,
Y. Kambayashi
,
S. Furudate
,
Aya Kakizaki
,
S. Aiba
EJD. European journal of dermatology
2014
Corpus ID: 31785809
BackgroundM2 macrophages play a critical role in the recruitment of T helper 2 (Th2) regulatory T cells (Treg).ObjectivesTo study…
Expand
2014
2014
Recurrent paraneoplastic wells syndrome in a patient with metastatic renal cell cancer.
Anand Rajpara
,
A. Liolios
,
G. Fraga
,
J. Blackmon
Dermatology Online Journal
2014
Corpus ID: 34509460
A 58-year-old man with a history of hyperlipidemia and hypertension presented to the dermatology clinic with a 3-month history of…
Expand
2013
2013
Eosinophilic cellulitis induced by subcutaneous administration of interferon-β.
Y. Kambayashi
,
T. Fujimura
,
M. Ishibashi
,
T. Haga
,
S. Aiba
Acta Dermato-Venereologica
2013
Corpus ID: 7295160
Eosinophilic cellulitis (EC) is described as erythematous plaques with perivascular and interstitial infiltration of eosinophils…
Expand
Review
2012
Review
2012
Eosinophilic cellulitis (Wells syndrome) in a pediatric patient: a case report and review of the literature.
J. Powell
,
Anne Ramsdell
,
Ilene L. Rothman
Cutis (New York, N.Y.)
2012
Corpus ID: 22057093
We report a 4-year-old boy who presented with multiple pruritic, annular, erythematous plaques on the lower extremities of 1 week…
Expand
2005
2005
Eosinophilic cellulitis of papulonodular presentation (Wells’ syndrome)
P. Ghislain
,
P. van Eeckhout
Journal of the European Academy of Dermatology…
2005
Corpus ID: 33221729
Eosinophilic cellulitis (Wells’ syndrome) is a rare condition of unknown aetiopathogenesis and is characterized by erythemal…
Expand
Highly Cited
2004
Highly Cited
2004
Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis
E. Aganna
,
Philip N. Hawkins
,
+13 authors
Michael F. McDermott
Genes and Immunity
2004
Corpus ID: 22460371
We investigated the hypothesis that low-penetrance mutations in genes (TNFRSF1A, MEFV and NALP3/CIAS1) associated with hereditary…
Expand
2000
2000
[Eosinophilic cellulitis (Wells syndrome)].
S. Plötz
,
D. Abeck
,
H. Behrendt
,
H. Simon
,
J. Ring
Der Hautarzt; Zeitschrift fur Dermatologie…
2000
Corpus ID: 19176363
Eosinophilic cellulitis (Wells' syndrome) is a rare disorder characterized clinically by recurrent erythematous plaques…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE